1. Home
  2. CADL vs GIG Comparison

CADL vs GIG Comparison

Compare CADL & GIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • GIG
  • Stock Information
  • Founded
  • CADL 1999
  • GIG 2024
  • Country
  • CADL United States
  • GIG United States
  • Employees
  • CADL N/A
  • GIG N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • GIG
  • Sector
  • CADL Health Care
  • GIG
  • Exchange
  • CADL Nasdaq
  • GIG NYSE
  • Market Cap
  • CADL 234.8M
  • GIG N/A
  • IPO Year
  • CADL 2021
  • GIG 2024
  • Fundamental
  • Price
  • CADL $4.76
  • GIG $10.22
  • Analyst Decision
  • CADL Strong Buy
  • GIG
  • Analyst Count
  • CADL 4
  • GIG 0
  • Target Price
  • CADL $21.00
  • GIG N/A
  • AVG Volume (30 Days)
  • CADL 864.6K
  • GIG 20.4K
  • Earning Date
  • CADL 05-13-2025
  • GIG 01-01-0001
  • Dividend Yield
  • CADL N/A
  • GIG N/A
  • EPS Growth
  • CADL N/A
  • GIG N/A
  • EPS
  • CADL N/A
  • GIG 0.10
  • Revenue
  • CADL N/A
  • GIG N/A
  • Revenue This Year
  • CADL N/A
  • GIG N/A
  • Revenue Next Year
  • CADL N/A
  • GIG N/A
  • P/E Ratio
  • CADL N/A
  • GIG $98.11
  • Revenue Growth
  • CADL N/A
  • GIG N/A
  • 52 Week Low
  • CADL $3.79
  • GIG $9.89
  • 52 Week High
  • CADL $14.60
  • GIG $10.24
  • Technical
  • Relative Strength Index (RSI)
  • CADL 41.42
  • GIG N/A
  • Support Level
  • CADL $4.80
  • GIG N/A
  • Resistance Level
  • CADL $5.34
  • GIG N/A
  • Average True Range (ATR)
  • CADL 0.33
  • GIG 0.00
  • MACD
  • CADL 0.10
  • GIG 0.00
  • Stochastic Oscillator
  • CADL 42.09
  • GIG 0.00

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: